{"id":"W2041349698","doi":"10.1586/14779072.2014.938055","title":"Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives","year":2014,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Acute coronary syndrome; TIMI; Clopidogrel; Internal medicine; P2Y12; Cardiology; Platelet aggregation inhibitor; Prasugrel; Secondary prevention; Aspirin; Warfarin; Myocardial infarction; Percutaneous coronary intervention; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001847087,0.0006136675,0.00577201,0.0006495022,0.00003737649,0.00002805134,0.0002287434,0.0002164039,0.0001874508],"category_scores_gemma":[0.0001251953,0.0004586337,0.004838586,0.0007005877,0.00004604753,0.0002200776,0.00005379188,0.0002904235,0.0000177274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002196036,"about_ca_system_score_gemma":0.0002051841,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001867139,"about_ca_topic_score_gemma":0.000001916465,"domain_scores_codex":[0.9960302,0.0008425929,0.001416193,0.0007614215,0.0005986176,0.0003510011],"domain_scores_gemma":[0.9981708,0.0001852907,0.0004179523,0.0009583004,0.0001706943,0.00009698689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001797693,0.00007316975,0.00007096694,0.02243942,0.003513173,0.00004407557,0.00009735606,0.000002099016,0.000001344792,0.00003368258,0.00102115,0.9725238],"study_design_scores_gemma":[0.003369762,0.0004910278,0.001300181,0.09388489,0.0008412296,0.0001007019,0.000017393,0.000003021432,0.000003089716,0.00001165385,0.8995733,0.000403775],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005568058,0.98685,0.0008561556,0.0001256455,0.0004530143,0.01105613,0.00005646142,0.00002941843,0.00001639506],"genre_scores_gemma":[0.0000925752,0.9965999,0.001019031,0.0001551412,0.000378591,0.0004875507,0.001100986,0.00009841652,0.00006783696],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.97212,"threshold_uncertainty_score":0.9997866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1087515911970197,"score_gpt":0.4210028351994481,"score_spread":0.3122512440024285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}